| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.4B | $8.4B | $7.0B | $6.5B | $5.7B | $1.4B | $1.5B | $1.4B |
| Cost of Revenue | — | — | $2.4B | $2.3B | $1.9B | $1.6B | $1.8B | $1.8B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | $1.3B | $1.3B | $1.2B |
| Operating Income | $2.2B | $2.4B | $2.1B | $1.9B | $1.9B | $0.4B | $0.5B | $0.5B |
| Net Income | $1.1B | $1.4B | $1.7B | $1.5B | $1.3B | $0.1B | $0.3B | $0.3B |
| EPS (Basic) | $2.36 | $3.21 | $3.82 | $3.28 | $2.71 | $0.30 | $0.55 | $0.65 |
| EPS (Diluted) | $2.35 | $3.18 | $3.76 | $3.25 | $2.69 | $0.30 | $0.54 | $0.64 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $25.6B | $24.6B | $23.4B | $22.7B | $23.2B | $22.8B | $22.4B | $20.1B |
| Current Assets | $2.8B | $2.3B | $2.2B | $2.0B | $1.8B | $2.3B | $2.2B | $1.5B |
| Cash & Equivalents | — | — | — | — | — | — | $0.9B | $0.9B |
| Total Liabilities | $20.5B | $19.8B | $18.7B | $18.5B | $19.4B | $19.1B | $18.1B | $16.5B |
| Current Liabilities | $2.9B | $2.4B | $2.1B | $2.1B | $1.9B | $1.6B | $1.7B | $1.4B |
| Stockholders' Equity | $3.6B | $3.1B | $2.9B | $2.5B | $2.2B | $2.2B | $2.5B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.7B | $1.5B | $1.3B | $1.5B | $1.7B | $0.9B | $1.5B | $1.2B |
| Investing Cash Flow | $-0.3B | $-0.7B | $0.0B | $-0.1B | $-1.1B | $-0.1B | $-0.0B | $-0.0B |
| Capital Expenditures | $0.3B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-1.4B | $-0.6B | $-1.4B | $-1.3B | $-1.1B | $-0.8B | $-0.8B | $-1.3B |